

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit biogenesis (GO:0042274) | 5.44828108 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.11966491 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.95471992 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.95471992 |
| 5 | viral transcription (GO:0019083) | 4.58360456 |
| 6 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.52655934 |
| 7 | translational termination (GO:0006415) | 4.34310643 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.29731773 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25128342 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.17375068 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.11644996 |
| 12 | DNA deamination (GO:0045006) | 4.09184242 |
| 13 | neuromuscular process controlling posture (GO:0050884) | 4.07588459 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02069451 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 3.91875496 |
| 16 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.90653044 |
| 17 | protein targeting to ER (GO:0045047) | 3.85427217 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84111623 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84111623 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.84111623 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84111623 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.84111623 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84111623 |
| 24 | protein localization to endoplasmic reticulum (GO:0070972) | 3.71850723 |
| 25 | central nervous system myelination (GO:0022010) | 3.66626758 |
| 26 | axon ensheathment in central nervous system (GO:0032291) | 3.66626758 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.66339774 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.65137671 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.64803279 |
| 30 | cellular protein complex disassembly (GO:0043624) | 3.64551604 |
| 31 | translational elongation (GO:0006414) | 3.62033882 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58196752 |
| 33 | viral life cycle (GO:0019058) | 3.52629376 |
| 34 | detection of bacterium (GO:0016045) | 3.52400406 |
| 35 | detection of other organism (GO:0098543) | 3.48159865 |
| 36 | response to peptidoglycan (GO:0032494) | 3.44090080 |
| 37 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.42410816 |
| 38 | sequestering of actin monomers (GO:0042989) | 3.40345078 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.38673288 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 3.37455137 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.36670690 |
| 42 | protein neddylation (GO:0045116) | 3.33762523 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33046477 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32263829 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 3.28275550 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26291614 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.25238389 |
| 48 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.23891425 |
| 49 | leukocyte aggregation (GO:0070486) | 3.22453219 |
| 50 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.20778860 |
| 51 | defense response to protozoan (GO:0042832) | 3.20736402 |
| 52 | microglial cell activation (GO:0001774) | 3.19938902 |
| 53 | response to type I interferon (GO:0034340) | 3.15887641 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.15350000 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.15350000 |
| 56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13109426 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 3.13109426 |
| 58 | granulocyte activation (GO:0036230) | 3.12186879 |
| 59 | neuronal action potential propagation (GO:0019227) | 3.11943376 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.11848368 |
| 61 | regulation of mast cell activation (GO:0033003) | 3.10642094 |
| 62 | B cell mediated immunity (GO:0019724) | 3.09999086 |
| 63 | protein complex biogenesis (GO:0070271) | 3.07002628 |
| 64 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.05561887 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05427417 |
| 66 | protein complex disassembly (GO:0043241) | 3.04633300 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.04574927 |
| 68 | response to protozoan (GO:0001562) | 3.03425997 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03041766 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.02506611 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02484845 |
| 72 | muscle organ morphogenesis (GO:0048644) | 2.95468430 |
| 73 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.93911733 |
| 74 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.91309558 |
| 75 | mannosylation (GO:0097502) | 2.90070434 |
| 76 | negative regulation of B cell mediated immunity (GO:0002713) | 2.89435967 |
| 77 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.89435967 |
| 78 | macromolecular complex disassembly (GO:0032984) | 2.88073374 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86959960 |
| 80 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.86043113 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85658037 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83706014 |
| 83 | positive thymic T cell selection (GO:0045059) | 2.82157211 |
| 84 | ear development (GO:0043583) | 2.80391807 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 2.79648149 |
| 86 | maturation of SSU-rRNA (GO:0030490) | 2.79403929 |
| 87 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79006155 |
| 88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79006155 |
| 89 | detection of external biotic stimulus (GO:0098581) | 2.78079925 |
| 90 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76357274 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.75451166 |
| 92 | cellular extravasation (GO:0045123) | 2.74676224 |
| 93 | macrophage activation (GO:0042116) | 2.74338095 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 2.69508233 |
| 95 | purinergic receptor signaling pathway (GO:0035587) | 2.68951351 |
| 96 | cellular response to interleukin-15 (GO:0071350) | 2.68734807 |
| 97 | germinal center formation (GO:0002467) | 2.68128102 |
| 98 | response to host immune response (GO:0052572) | 2.68041123 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.68041123 |
| 100 | respiratory system process (GO:0003016) | 2.66333542 |
| 101 | respiratory burst (GO:0045730) | 2.66324316 |
| 102 | response to interferon-beta (GO:0035456) | 2.66228812 |
| 103 | mast cell activation (GO:0045576) | 2.66018775 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.65736065 |
| 105 | protein targeting to membrane (GO:0006612) | 2.65550548 |
| 106 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65414665 |
| 107 | NIK/NF-kappaB signaling (GO:0038061) | 2.64626480 |
| 108 | negative T cell selection (GO:0043383) | 2.64460426 |
| 109 | regulation of regulated secretory pathway (GO:1903305) | 2.63954303 |
| 110 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62504920 |
| 111 | synaptic vesicle exocytosis (GO:0016079) | 2.62492560 |
| 112 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.62358522 |
| 113 | negative regulation of innate immune response (GO:0045824) | 2.62256533 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.61596150 |
| 115 | neutrophil activation involved in immune response (GO:0002283) | 2.60986238 |
| 116 | neurofilament cytoskeleton organization (GO:0060052) | 2.60764085 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.59493327 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.59493327 |
| 119 | NADH dehydrogenase complex assembly (GO:0010257) | 2.59493327 |
| 120 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59026763 |
| 121 | response to interleukin-15 (GO:0070672) | 2.58516661 |
| 122 | negative regulation of heart rate (GO:0010459) | 2.57048226 |
| 123 | reactive oxygen species biosynthetic process (GO:1903409) | 2.56831324 |
| 124 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.56732724 |
| 125 | regulation of type 2 immune response (GO:0002828) | 2.56613084 |
| 126 | GPI anchor biosynthetic process (GO:0006506) | 2.56160081 |
| 127 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.54668104 |
| 128 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54142067 |
| 129 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.53904024 |
| 130 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.53904024 |
| 131 | activated T cell proliferation (GO:0050798) | 2.53805070 |
| 132 | translational initiation (GO:0006413) | 2.53596132 |
| 133 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.53326139 |
| 134 | translation (GO:0006412) | 2.50004634 |
| 135 | ncRNA 3-end processing (GO:0043628) | 2.49409058 |
| 136 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.49382239 |
| 137 | regulation of tolerance induction (GO:0002643) | 2.49339189 |
| 138 | negative regulation of interleukin-6 production (GO:0032715) | 2.49295173 |
| 139 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.48887309 |
| 140 | regulation of lamellipodium assembly (GO:0010591) | 2.48786738 |
| 141 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48703812 |
| 142 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.47283511 |
| 143 | regulation of B cell differentiation (GO:0045577) | 2.47261222 |
| 144 | positive regulation of interleukin-17 production (GO:0032740) | 2.47108806 |
| 145 | phagosome maturation (GO:0090382) | 2.45437183 |
| 146 | respiratory electron transport chain (GO:0022904) | 2.44864143 |
| 147 | regulation of germinal center formation (GO:0002634) | 2.43668695 |
| 148 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.43298773 |
| 149 | regulation of axon regeneration (GO:0048679) | 2.43114388 |
| 150 | regulation of neuron projection regeneration (GO:0070570) | 2.43114388 |
| 151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42690123 |
| 152 | protein localization to synapse (GO:0035418) | 2.42521457 |
| 153 | electron transport chain (GO:0022900) | 2.40299402 |
| 154 | cytochrome complex assembly (GO:0017004) | 2.36880044 |
| 155 | neuron cell-cell adhesion (GO:0007158) | 2.36707139 |
| 156 | respiratory chain complex IV assembly (GO:0008535) | 2.36084614 |
| 157 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.35952950 |
| 158 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.35191883 |
| 159 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.33253489 |
| 160 | negative regulation of type 2 immune response (GO:0002829) | 2.33027236 |
| 161 | establishment of mitochondrion localization (GO:0051654) | 2.32544441 |
| 162 | C-terminal protein lipidation (GO:0006501) | 2.30066213 |
| 163 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.29739199 |
| 164 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.29419859 |
| 165 | establishment of monopolar cell polarity (GO:0061162) | 2.29419859 |
| 166 | nucleoside diphosphate catabolic process (GO:0009134) | 2.27149501 |
| 167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.26917672 |
| 168 | ATP synthesis coupled proton transport (GO:0015986) | 2.26835063 |
| 169 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.26835063 |
| 170 | regulation of protein targeting to membrane (GO:0090313) | 2.26277698 |
| 171 | neurotransmitter uptake (GO:0001504) | 2.25005578 |
| 172 | peripheral nervous system neuron development (GO:0048935) | 2.24657932 |
| 173 | leukocyte degranulation (GO:0043299) | 2.23465439 |
| 174 | mast cell degranulation (GO:0043303) | 2.21992010 |
| 175 | mast cell activation involved in immune response (GO:0002279) | 2.21992010 |
| 176 | synaptic vesicle maturation (GO:0016188) | 2.21611732 |
| 177 | ribosomal large subunit biogenesis (GO:0042273) | 2.21093060 |
| 178 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.20222029 |
| 179 | GPI anchor metabolic process (GO:0006505) | 2.19958738 |
| 180 | B cell receptor signaling pathway (GO:0050853) | 2.18880775 |
| 181 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.18502430 |
| 182 | cellular component biogenesis (GO:0044085) | 2.16394518 |
| 183 | neutrophil activation (GO:0042119) | 2.16286051 |
| 184 | detection of temperature stimulus (GO:0016048) | 2.15123732 |
| 185 | transepithelial transport (GO:0070633) | 2.14019153 |
| 186 | establishment of protein localization to membrane (GO:0090150) | 2.13933580 |
| 187 | C-terminal protein amino acid modification (GO:0018410) | 2.13610680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.09327586 |
| 2 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.22329534 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.88657257 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81806954 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71321799 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.43676307 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36980515 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33888755 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29075286 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28404388 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.21749662 |
| 12 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.15365172 |
| 13 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.15365172 |
| 14 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.15365172 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14783518 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.13511169 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.11268187 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05361715 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.96648759 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.94812994 |
| 21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94682796 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.94515518 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93862537 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92474367 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91477534 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90690274 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85467778 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85017137 |
| 29 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.83401268 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76468554 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75179938 |
| 32 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.72003296 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70736808 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.68739199 |
| 35 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.65453309 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.64520990 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.62653837 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62187939 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.60258680 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59271895 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58834960 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.56200452 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.55610313 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52561690 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52441654 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.51716986 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48375495 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44675789 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.44642307 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.43739998 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43341864 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42798171 |
| 53 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42684235 |
| 54 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42644880 |
| 55 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.42471205 |
| 56 | * P68_20966046_ChIP-Seq_HELA_Human | 1.41348742 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39823138 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35480387 |
| 59 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.35026297 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34839683 |
| 61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34682059 |
| 62 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33299894 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32872109 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32629656 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32556014 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31524088 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31207315 |
| 68 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30647359 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29822708 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29446346 |
| 71 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28963780 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27309169 |
| 73 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.27077944 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.27060368 |
| 75 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25874026 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25820825 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.25380352 |
| 78 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.25200926 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23416093 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21729046 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21423928 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20453241 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18893256 |
| 84 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.18069973 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17979773 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17481382 |
| 87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16531903 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16165601 |
| 89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15702401 |
| 90 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15136237 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15013411 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14967417 |
| 93 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14839006 |
| 94 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14579645 |
| 95 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.14353461 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14189187 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13920236 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 1.13475369 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13033933 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12839951 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12786950 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12419264 |
| 103 | MYC_22102868_ChIP-Seq_BL_Human | 1.12004422 |
| 104 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11659700 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11560650 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11365826 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10981886 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.09927018 |
| 109 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09607928 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09556624 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09056938 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 1.08978639 |
| 113 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08707809 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08499173 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08322743 |
| 116 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.07825114 |
| 117 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07244942 |
| 118 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06910292 |
| 119 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06260141 |
| 120 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06022563 |
| 121 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05751233 |
| 122 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.05067878 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04985591 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04804708 |
| 125 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04643789 |
| 126 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04560597 |
| 127 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04480661 |
| 128 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04117335 |
| 129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04017114 |
| 130 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03929432 |
| 131 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.03138064 |
| 132 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03119324 |
| 133 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02677085 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02314509 |
| 135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02261056 |
| 136 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02004463 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01874250 |
| 138 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00917307 |
| 139 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00703056 |
| 140 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00431291 |
| 141 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99916311 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99440335 |
| 143 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99247885 |
| 144 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98810957 |
| 145 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.97896562 |
| 146 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.97758364 |
| 147 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97676048 |
| 148 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97628045 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94846435 |
| 150 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94368304 |
| 151 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93620431 |
| 152 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93061181 |
| 153 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92282883 |
| 154 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89309123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003941_abnormal_skin_development | 3.50043026 |
| 2 | MP0001986_abnormal_taste_sensitivity | 3.44227156 |
| 3 | MP0003880_abnormal_central_pattern | 2.98374448 |
| 4 | MP0001968_abnormal_touch/_nociception | 2.73697567 |
| 5 | MP0002735_abnormal_chemical_nociception | 2.69978354 |
| 6 | MP0002736_abnormal_nociception_after | 2.49174243 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.37164661 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.34077520 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.32190033 |
| 10 | MP0009785_altered_susceptibility_to | 2.27975057 |
| 11 | MP0002272_abnormal_nervous_system | 2.22004742 |
| 12 | MP0001970_abnormal_pain_threshold | 2.17412264 |
| 13 | MP0005671_abnormal_response_to | 2.13670632 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.13239494 |
| 15 | MP0004142_abnormal_muscle_tone | 2.13200976 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.12565576 |
| 17 | MP0004270_analgesia | 2.10271450 |
| 18 | MP0005464_abnormal_platelet_physiology | 1.99498078 |
| 19 | MP0002064_seizures | 1.99372866 |
| 20 | MP0001188_hyperpigmentation | 1.99289595 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.96170986 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.94269451 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.92239745 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.92000194 |
| 25 | MP0001790_abnormal_immune_system | 1.91498178 |
| 26 | MP0005387_immune_system_phenotype | 1.91498178 |
| 27 | MP0009745_abnormal_behavioral_response | 1.90694459 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.88499839 |
| 29 | MP0000920_abnormal_myelination | 1.86338929 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.84736203 |
| 31 | MP0001529_abnormal_vocalization | 1.79546865 |
| 32 | MP0009046_muscle_twitch | 1.79472673 |
| 33 | MP0001800_abnormal_humoral_immune | 1.78969052 |
| 34 | MP0009764_decreased_sensitivity_to | 1.77681519 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.76857213 |
| 36 | MP0003866_abnormal_defecation | 1.74808341 |
| 37 | MP0001905_abnormal_dopamine_level | 1.72692050 |
| 38 | MP0009278_abnormal_bone_marrow | 1.68904876 |
| 39 | MP0000685_abnormal_immune_system | 1.68537338 |
| 40 | MP0002723_abnormal_immune_serum | 1.65583995 |
| 41 | MP0003075_altered_response_to | 1.63264807 |
| 42 | MP0003724_increased_susceptibility_to | 1.62818387 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.61425406 |
| 44 | MP0005025_abnormal_response_to | 1.59227031 |
| 45 | MP0001819_abnormal_immune_cell | 1.57489168 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.56111822 |
| 47 | MP0004510_myositis | 1.51033897 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.50833705 |
| 49 | MP0003436_decreased_susceptibility_to | 1.45801377 |
| 50 | MP0004947_skin_inflammation | 1.44492173 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.43401466 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.42713215 |
| 53 | MP0003303_peritoneal_inflammation | 1.38115299 |
| 54 | MP0001486_abnormal_startle_reflex | 1.38018982 |
| 55 | MP0008469_abnormal_protein_level | 1.36029750 |
| 56 | MP0002419_abnormal_innate_immunity | 1.35446838 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.31714178 |
| 58 | MP0000604_amyloidosis | 1.31141255 |
| 59 | MP0002572_abnormal_emotion/affect_behav | 1.30795296 |
| 60 | MP0003690_abnormal_glial_cell | 1.29827225 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.27526632 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.25480423 |
| 63 | MP0004742_abnormal_vestibular_system | 1.25436557 |
| 64 | MP0002063_abnormal_learning/memory/cond | 1.24341015 |
| 65 | MP0008260_abnormal_autophagy | 1.24239823 |
| 66 | MP0003879_abnormal_hair_cell | 1.23923559 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.23283545 |
| 68 | MP0001664_abnormal_digestion | 1.22509203 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.21597793 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.21192197 |
| 71 | MP0002933_joint_inflammation | 1.20186446 |
| 72 | MP0006292_abnormal_olfactory_placode | 1.20168869 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.19241273 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.19241273 |
| 75 | MP0005310_abnormal_salivary_gland | 1.19227140 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.19062513 |
| 77 | MP0008569_lethality_at_weaning | 1.18114524 |
| 78 | MP0000716_abnormal_immune_system | 1.16158270 |
| 79 | MP0001984_abnormal_olfaction | 1.14435177 |
| 80 | MP0005171_absent_coat_pigmentation | 1.13410747 |
| 81 | MP0002184_abnormal_innervation | 1.12579721 |
| 82 | MP0006082_CNS_inflammation | 1.12484537 |
| 83 | MP0002398_abnormal_bone_marrow | 1.11202466 |
| 84 | MP0005166_decreased_susceptibility_to | 1.10774130 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.10142141 |
| 86 | MP0003136_yellow_coat_color | 1.08836374 |
| 87 | MP0009840_abnormal_foam_cell | 1.08682917 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 1.08344472 |
| 89 | MP0002653_abnormal_ependyma_morphology | 1.07623869 |
| 90 | MP0004858_abnormal_nervous_system | 1.07212008 |
| 91 | MP0002751_abnormal_autonomic_nervous | 1.07004655 |
| 92 | MP0005451_abnormal_body_composition | 1.04906831 |
| 93 | MP0002229_neurodegeneration | 1.03526988 |
| 94 | MP0003329_amyloid_beta_deposits | 1.03398869 |
| 95 | MP0001663_abnormal_digestive_system | 1.02503887 |
| 96 | MP0000955_abnormal_spinal_cord | 1.00575866 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.99941768 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.98082410 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.97743420 |
| 100 | MP0002822_catalepsy | 0.97709249 |
| 101 | MP0002132_abnormal_respiratory_system | 0.96710168 |
| 102 | MP0002405_respiratory_system_inflammati | 0.96113893 |
| 103 | MP0001873_stomach_inflammation | 0.95399133 |
| 104 | MP0000343_altered_response_to | 0.95175739 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.93117624 |
| 106 | MP0002277_abnormal_respiratory_mucosa | 0.92826624 |
| 107 | MP0001440_abnormal_grooming_behavior | 0.92805159 |
| 108 | MP0005410_abnormal_fertilization | 0.92399839 |
| 109 | MP0005535_abnormal_body_temperature | 0.92286681 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.90859171 |
| 111 | MP0008874_decreased_physiological_sensi | 0.90809400 |
| 112 | MP0000689_abnormal_spleen_morphology | 0.90133881 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.86425383 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.85794669 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.84705489 |
| 116 | MP0002429_abnormal_blood_cell | 0.84377456 |
| 117 | MP0002882_abnormal_neuron_morphology | 0.83184975 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.83044753 |
| 119 | MP0008004_abnormal_stomach_pH | 0.81862551 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.81456643 |
| 121 | MP0004381_abnormal_hair_follicle | 0.80927584 |
| 122 | MP0003787_abnormal_imprinting | 0.79988543 |
| 123 | MP0002066_abnormal_motor_capabilities/c | 0.78728077 |
| 124 | MP0003634_abnormal_glial_cell | 0.78401033 |
| 125 | MP0002722_abnormal_immune_system | 0.78335089 |
| 126 | MP0001348_abnormal_lacrimal_gland | 0.77689496 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.77295029 |
| 128 | MP0005390_skeleton_phenotype | 0.77063636 |
| 129 | MP0003633_abnormal_nervous_system | 0.76820326 |
| 130 | MP0005379_endocrine/exocrine_gland_phen | 0.76468209 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72255315 |
| 132 | MP0000858_altered_metastatic_potential | 0.71562160 |
| 133 | MP0008872_abnormal_physiological_respon | 0.70540677 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.69562442 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.69368303 |
| 136 | MP0004883_abnormal_blood_vessel | 0.68976426 |
| 137 | MP0004130_abnormal_muscle_cell | 0.65900436 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.64676768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.92610915 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.82174652 |
| 3 | Myokymia (HP:0002411) | 4.48492882 |
| 4 | Orchitis (HP:0100796) | 4.41599656 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.21091122 |
| 6 | Optic neuritis (HP:0100653) | 4.21091122 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.45702848 |
| 8 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.44346737 |
| 9 | IgM deficiency (HP:0002850) | 3.43092982 |
| 10 | Stomatitis (HP:0010280) | 3.38033934 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.32540186 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.31378927 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26334404 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26334404 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26334404 |
| 16 | Encephalitis (HP:0002383) | 3.23946539 |
| 17 | Increased IgE level (HP:0003212) | 3.23284864 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.22546945 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.21486742 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.21486742 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 3.19945971 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.15784369 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.05287735 |
| 24 | 3-Methylglutaconic aciduria (HP:0003535) | 2.98784233 |
| 25 | Reticulocytopenia (HP:0001896) | 2.94151212 |
| 26 | Mitochondrial inheritance (HP:0001427) | 2.93583366 |
| 27 | Ulnar claw (HP:0001178) | 2.91463922 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.88937673 |
| 29 | Petechiae (HP:0000967) | 2.88023731 |
| 30 | Agammaglobulinemia (HP:0004432) | 2.87388428 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.78512929 |
| 32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77452362 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 2.76391749 |
| 34 | Hypothermia (HP:0002045) | 2.73208397 |
| 35 | Pulmonary infiltrates (HP:0002113) | 2.71403273 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.71200602 |
| 37 | Chronic otitis media (HP:0000389) | 2.70062533 |
| 38 | Episodic fever (HP:0001954) | 2.69881176 |
| 39 | Peripheral hypomyelination (HP:0007182) | 2.68932182 |
| 40 | Hemoptysis (HP:0002105) | 2.66642198 |
| 41 | Mutism (HP:0002300) | 2.63688891 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.62473316 |
| 43 | Meningitis (HP:0001287) | 2.62317342 |
| 44 | Purpura (HP:0000979) | 2.62162310 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.57842395 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.57028181 |
| 47 | Limb dystonia (HP:0002451) | 2.56265121 |
| 48 | Type I transferrin isoform profile (HP:0003642) | 2.56203671 |
| 49 | Urticaria (HP:0001025) | 2.54542916 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53315861 |
| 51 | Obstructive lung disease (HP:0006536) | 2.53315861 |
| 52 | Hepatocellular necrosis (HP:0001404) | 2.49713186 |
| 53 | Macrocytic anemia (HP:0001972) | 2.45081083 |
| 54 | Retinal dysplasia (HP:0007973) | 2.44983833 |
| 55 | Increased IgM level (HP:0003496) | 2.44236259 |
| 56 | Renal Fanconi syndrome (HP:0001994) | 2.43238671 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.41839521 |
| 58 | Pustule (HP:0200039) | 2.41603490 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.40779451 |
| 60 | Leukocytosis (HP:0001974) | 2.37890565 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.36762733 |
| 62 | Diplopia (HP:0000651) | 2.35516544 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.35516544 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33845987 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33845987 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33845987 |
| 67 | Leukodystrophy (HP:0002415) | 2.33422957 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.33217842 |
| 69 | Increased serum ferritin (HP:0003281) | 2.33195964 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.31752975 |
| 71 | Ankle clonus (HP:0011448) | 2.29634297 |
| 72 | Atonic seizures (HP:0010819) | 2.28930222 |
| 73 | Recurrent viral infections (HP:0004429) | 2.28050505 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.25185114 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23783276 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.21261735 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21156531 |
| 78 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20545121 |
| 79 | Abnormality of magnesium homeostasis (HP:0004921) | 2.20389904 |
| 80 | Acute encephalopathy (HP:0006846) | 2.19912817 |
| 81 | Granulocytopenia (HP:0001913) | 2.19854234 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.19669703 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.18919399 |
| 84 | Sensory axonal neuropathy (HP:0003390) | 2.17916092 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15575341 |
| 86 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15575341 |
| 87 | Epistaxis (HP:0000421) | 2.15314073 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 2.15222899 |
| 89 | Increased CSF lactate (HP:0002490) | 2.14611134 |
| 90 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.13558566 |
| 91 | Optic disc pallor (HP:0000543) | 2.13364194 |
| 92 | Hypochromic anemia (HP:0001931) | 2.13284346 |
| 93 | Poor suck (HP:0002033) | 2.12620575 |
| 94 | Chest pain (HP:0100749) | 2.10848824 |
| 95 | Parakeratosis (HP:0001036) | 2.10251059 |
| 96 | Nasal polyposis (HP:0100582) | 2.08371663 |
| 97 | Anorexia (HP:0002039) | 2.08048439 |
| 98 | Polyphagia (HP:0002591) | 2.08007571 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.07489330 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.07065772 |
| 101 | Dysphonia (HP:0001618) | 2.06847746 |
| 102 | Pallor (HP:0000980) | 2.06678498 |
| 103 | Eosinophilia (HP:0001880) | 2.06564250 |
| 104 | Mucopolysacchariduria (HP:0008155) | 2.05518061 |
| 105 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05518061 |
| 106 | Pulmonary embolism (HP:0002204) | 2.05062174 |
| 107 | Abnormality of the nasal mucosa (HP:0000433) | 2.04666959 |
| 108 | Vasculitis (HP:0002633) | 2.04491141 |
| 109 | Abnormality of the pleura (HP:0002103) | 2.04405050 |
| 110 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04196207 |
| 111 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04196207 |
| 112 | Focal motor seizures (HP:0011153) | 2.04093968 |
| 113 | Neuroendocrine neoplasm (HP:0100634) | 2.03703316 |
| 114 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.03548496 |
| 115 | Vertigo (HP:0002321) | 1.99898023 |
| 116 | Amyloidosis (HP:0011034) | 1.99039115 |
| 117 | Papilledema (HP:0001085) | 1.97788866 |
| 118 | Split foot (HP:0001839) | 1.97404837 |
| 119 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96952111 |
| 120 | Acne (HP:0001061) | 1.96332792 |
| 121 | Pheochromocytoma (HP:0002666) | 1.96104137 |
| 122 | Lymphopenia (HP:0001888) | 1.96086076 |
| 123 | Papilloma (HP:0012740) | 1.94999955 |
| 124 | Verrucae (HP:0200043) | 1.94999955 |
| 125 | Gingivitis (HP:0000230) | 1.94854400 |
| 126 | Abnormality of T cell number (HP:0011839) | 1.94832200 |
| 127 | Memory impairment (HP:0002354) | 1.94764654 |
| 128 | Recurrent skin infections (HP:0001581) | 1.94477307 |
| 129 | Joint swelling (HP:0001386) | 1.93583545 |
| 130 | Microvesicular hepatic steatosis (HP:0001414) | 1.93536993 |
| 131 | Abnormality of T cells (HP:0002843) | 1.93392721 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.93133353 |
| 133 | Hypergammaglobulinemia (HP:0010702) | 1.93030510 |
| 134 | Febrile seizures (HP:0002373) | 1.93019283 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92107790 |
| 136 | Sepsis (HP:0100806) | 1.90684653 |
| 137 | T lymphocytopenia (HP:0005403) | 1.90666640 |
| 138 | Myositis (HP:0100614) | 1.89897625 |
| 139 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.89391988 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.87898419 |
| 141 | Focal seizures (HP:0007359) | 1.87508541 |
| 142 | Anxiety (HP:0000739) | 1.84868964 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.83652250 |
| 144 | Recurrent sinusitis (HP:0011108) | 1.81772494 |
| 145 | IgG deficiency (HP:0004315) | 1.81360763 |
| 146 | Recurrent fungal infections (HP:0002841) | 1.81254165 |
| 147 | Hypomagnesemia (HP:0002917) | 1.78764059 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.78706577 |
| 149 | Increased hepatocellular lipid droplets (HP:0006565) | 1.76749787 |
| 150 | Upper limb muscle weakness (HP:0003484) | 1.75372204 |
| 151 | Recurrent pneumonia (HP:0006532) | 1.74005552 |
| 152 | Redundant skin (HP:0001582) | 1.73668047 |
| 153 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73538547 |
| 154 | Hyperparathyroidism (HP:0000843) | 1.73411616 |
| 155 | Sex reversal (HP:0012245) | 1.73303910 |
| 156 | Abnormal sex determination (HP:0012244) | 1.73303910 |
| 157 | Exertional dyspnea (HP:0002875) | 1.73028580 |
| 158 | Increased serum lactate (HP:0002151) | 1.70936596 |
| 159 | Increased intramyocellular lipid droplets (HP:0012240) | 1.70270382 |
| 160 | Cellulitis (HP:0100658) | 1.70177725 |
| 161 | Esotropia (HP:0000565) | 1.69785668 |
| 162 | Respiratory failure (HP:0002878) | 1.69016174 |
| 163 | Loss of speech (HP:0002371) | 1.68656385 |
| 164 | Chronic sinusitis (HP:0011109) | 1.68331053 |
| 165 | Visual hallucinations (HP:0002367) | 1.66639389 |
| 166 | Vacuolated lymphocytes (HP:0001922) | 1.66492460 |
| 167 | Severe combined immunodeficiency (HP:0004430) | 1.66218713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.73188625 |
| 2 | TLK1 | 3.71262644 |
| 3 | TESK2 | 3.04452337 |
| 4 | MAP3K12 | 2.74027905 |
| 5 | CASK | 2.59602856 |
| 6 | ERN1 | 2.57227090 |
| 7 | NME2 | 2.39243938 |
| 8 | RIPK4 | 2.39195165 |
| 9 | PRPF4B | 2.25657574 |
| 10 | MAP4K1 | 2.25560297 |
| 11 | BLK | 2.10318103 |
| 12 | CDK19 | 2.10164903 |
| 13 | MAPKAPK3 | 2.04998611 |
| 14 | TAOK3 | 1.97242814 |
| 15 | SIK2 | 1.95810288 |
| 16 | MAP3K14 | 1.75084616 |
| 17 | VRK1 | 1.74854927 |
| 18 | IRAK4 | 1.67945109 |
| 19 | TXK | 1.56806460 |
| 20 | TAOK1 | 1.52392628 |
| 21 | LIMK1 | 1.50478228 |
| 22 | JAK3 | 1.45116512 |
| 23 | FES | 1.44882084 |
| 24 | MAPKAPK5 | 1.43652004 |
| 25 | NME1 | 1.41874659 |
| 26 | TNIK | 1.36290055 |
| 27 | TESK1 | 1.35763274 |
| 28 | UHMK1 | 1.33664175 |
| 29 | TNK2 | 1.29184348 |
| 30 | MST4 | 1.26893465 |
| 31 | MAP2K3 | 1.25808295 |
| 32 | TEC | 1.25365144 |
| 33 | SYK | 1.22231971 |
| 34 | DAPK3 | 1.17924248 |
| 35 | DYRK2 | 1.14605343 |
| 36 | CSNK1G3 | 1.14143910 |
| 37 | NTRK3 | 1.13941396 |
| 38 | MARK3 | 1.11775008 |
| 39 | PIM2 | 1.10015683 |
| 40 | ADRBK2 | 1.09797617 |
| 41 | TAOK2 | 1.04755740 |
| 42 | STK39 | 1.04218192 |
| 43 | GRK7 | 1.01931821 |
| 44 | CSF1R | 1.01715811 |
| 45 | MAPK13 | 1.01682686 |
| 46 | MINK1 | 1.00176085 |
| 47 | GRK5 | 0.99963403 |
| 48 | MARK2 | 0.99645746 |
| 49 | MAP3K3 | 0.97479354 |
| 50 | BTK | 0.97066160 |
| 51 | ZAP70 | 0.95363831 |
| 52 | MAPK15 | 0.94827550 |
| 53 | YES1 | 0.93485596 |
| 54 | KIT | 0.93148690 |
| 55 | MAP2K7 | 0.92093916 |
| 56 | BCKDK | 0.91899758 |
| 57 | JAK1 | 0.91008830 |
| 58 | RPS6KB2 | 0.89803568 |
| 59 | MAP3K1 | 0.89648984 |
| 60 | PKN1 | 0.89130724 |
| 61 | CLK1 | 0.89121871 |
| 62 | OXSR1 | 0.88511470 |
| 63 | MAP3K11 | 0.87881355 |
| 64 | JAK2 | 0.86812079 |
| 65 | CAMKK1 | 0.85048684 |
| 66 | ZAK | 0.84735006 |
| 67 | MAPK12 | 0.84087046 |
| 68 | CSNK1A1L | 0.83051295 |
| 69 | SIK3 | 0.82570547 |
| 70 | LCK | 0.82521877 |
| 71 | CAMKK2 | 0.81938755 |
| 72 | PDK1 | 0.81932777 |
| 73 | LYN | 0.80997648 |
| 74 | PTK2B | 0.80315395 |
| 75 | MAP2K6 | 0.80203144 |
| 76 | EIF2AK3 | 0.78054413 |
| 77 | ACVR1B | 0.76822962 |
| 78 | ARAF | 0.74310969 |
| 79 | IKBKB | 0.71811998 |
| 80 | DAPK2 | 0.68150336 |
| 81 | ROCK2 | 0.66452718 |
| 82 | KDR | 0.66265972 |
| 83 | NTRK2 | 0.65959284 |
| 84 | PRKCQ | 0.65421759 |
| 85 | TBK1 | 0.65396162 |
| 86 | GRK6 | 0.65326926 |
| 87 | DAPK1 | 0.64050282 |
| 88 | IKBKE | 0.63937150 |
| 89 | CSNK1G2 | 0.62953897 |
| 90 | HCK | 0.62924184 |
| 91 | PINK1 | 0.62653442 |
| 92 | CDC42BPA | 0.61748298 |
| 93 | FYN | 0.60641390 |
| 94 | ITK | 0.60616995 |
| 95 | PRKD2 | 0.60588655 |
| 96 | MYLK | 0.60073055 |
| 97 | PDPK1 | 0.59631806 |
| 98 | MAP3K13 | 0.59607588 |
| 99 | EPHB1 | 0.59575867 |
| 100 | MATK | 0.58685442 |
| 101 | CSNK1G1 | 0.58275869 |
| 102 | MARK1 | 0.58233156 |
| 103 | CAMK2B | 0.58038806 |
| 104 | MAP3K9 | 0.57793436 |
| 105 | NTRK1 | 0.57362904 |
| 106 | PRKCH | 0.56218268 |
| 107 | GRK1 | 0.56169141 |
| 108 | STK11 | 0.54964602 |
| 109 | CAMK2D | 0.53393214 |
| 110 | FGR | 0.53260595 |
| 111 | ADRBK1 | 0.52572977 |
| 112 | MAP2K2 | 0.52556987 |
| 113 | HIPK2 | 0.51548412 |
| 114 | MAP3K5 | 0.49919345 |
| 115 | MAP2K4 | 0.48813648 |
| 116 | CDK5 | 0.48523080 |
| 117 | RPS6KA5 | 0.48253227 |
| 118 | PRKCZ | 0.47965242 |
| 119 | PRKCE | 0.47666348 |
| 120 | CSK | 0.47440592 |
| 121 | PAK6 | 0.47347249 |
| 122 | CDK14 | 0.47136332 |
| 123 | PIM1 | 0.46610637 |
| 124 | TYK2 | 0.45757138 |
| 125 | PRKCD | 0.45609763 |
| 126 | AURKA | 0.45573933 |
| 127 | BMPR2 | 0.44542808 |
| 128 | EIF2AK1 | 0.43608063 |
| 129 | NEK6 | 0.43442385 |
| 130 | CAMK1 | 0.43161695 |
| 131 | MAP4K2 | 0.43009693 |
| 132 | DYRK1B | 0.42376936 |
| 133 | IRAK3 | 0.42037436 |
| 134 | CHUK | 0.37076791 |
| 135 | MAPK4 | 0.36934699 |
| 136 | KSR2 | 0.35832633 |
| 137 | TGFBR2 | 0.35671407 |
| 138 | MAPK7 | 0.35667910 |
| 139 | STK10 | 0.35039776 |
| 140 | PRKD1 | 0.34866159 |
| 141 | RPS6KA6 | 0.34592840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.45977645 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.42361982 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.84834188 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58991825 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.38390253 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.32312394 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.19630146 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95888577 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89703276 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84430067 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84301762 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.82634734 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75741591 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.69938273 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.65496375 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57123729 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.54140136 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50682230 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.44468242 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44344140 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43198258 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40116694 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34671204 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33139905 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32127994 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31573856 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30731983 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30490751 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25096895 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24531146 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.21633169 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19108105 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17888709 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17687272 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.15968052 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.12262148 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10541959 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.10173922 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09969448 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.09678424 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09636086 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07597850 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07452141 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07166029 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07149774 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06615866 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06432489 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02845660 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01043012 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.00600474 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99741701 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97249604 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97015688 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96973330 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95304063 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95099260 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90808555 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89998024 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.89320439 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.89020755 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85549726 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85245366 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83920428 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83500691 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.83480581 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82039759 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81960808 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80608933 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.79810180 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.79608581 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79006439 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74786870 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74179611 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71876815 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71619000 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70610468 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70262092 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.69585685 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.68988795 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.68963113 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68857816 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68553043 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68505515 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68293112 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.67887245 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66850901 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.66689327 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62578914 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62541743 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62173317 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61592264 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59379255 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57999355 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57847539 |
| 95 | Long-term depression_Homo sapiens_hsa04730 | 0.57479854 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57301718 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57298618 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56950661 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55676493 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54833193 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54303352 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53818986 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.53630935 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.53615251 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53498604 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.52851438 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51968957 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.49374182 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49334862 |
| 110 | Spliceosome_Homo sapiens_hsa03040 | 0.46803367 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46436369 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45467614 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45355138 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45234987 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44906297 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.44242118 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.44114459 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43610444 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.42766618 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42389660 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42383113 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42084026 |
| 123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41703738 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41443639 |
| 125 | Mismatch repair_Homo sapiens_hsa03430 | 0.41420884 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40976020 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37783969 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33399489 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32504728 |
| 130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32305054 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.32069434 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31968556 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31594849 |
| 134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30791663 |

